Startseite

Studien & Berichte

Whitepaper, Forschungsberichte und Marktdaten

Global Finished Dosage Manufacturing Landscape 2026Studien & Berichte
5. Okt. 2026•15 Min. Lesezeit
Global Finished Dosage Manufacturing Landscape 2026
Tablets, injectables, capsules and eleven other dosage forms: how finished dosage manufacturers and listings are distributed by form and by country in PharmaCountry's database, with the data origin stated.
148
3
Global Pharmaceutical Supplier Landscape 2026Studien & Berichte
21. Sept. 2026•14 Min. Lesezeit
Global Pharmaceutical Supplier Landscape 2026
Explore the global pharmaceutical supplier landscape using PharmaCountry's database of pharmaceutical companies, manufacturers, products and services by country and category.
361
4
2
Studien & Berichte
28. Sept. 2026•1 Min. Lesezeit
Kyung Hee University Pharmacy Student Wins ACCP 2026 M. Kelli Jordan Award
Kyung Hee University pharmacy student Yu Jeong-min was selected as the 2026 M. Kelli Jordan Award winner, the first Korean to receive this ACCP honor.
Studien & Berichte
28. Sept. 2026•1 Min. Lesezeit
Pharmacies Use Claude AI with Naver Data Lab and Notion to Track Ingredient Demand Trends
Pharmacies are linking Claude AI to Naver Data Lab and Notion to capture click‑through data for specific ingredients and store monthly trends, improving demand visibility.
Studien & Berichte
28. Sept. 2026•1 Min. Lesezeit
Japanese Study Evaluates Makmundong-tang for Post‑Mycoplasma Pneumoniae Cough
Japanese researchers assess the traditional formula Makmundong‑tang for persistent cough after Mycoplasma pneumoniae infection, a common issue despite macrolide therapy.
Studien & Berichte
27. Sept. 2026•1 Min. Lesezeit
Acute bronchitis ranks second among frequent diagnoses in Korea, KOSIS data shows
KOSIS data for 2019‑2024 places acute bronchitis as the second most common diagnosis after gingivitis, highlighting its prevalence in clinical practice.
Studien & Berichte
27. Sept. 2026•1 Min. Lesezeit
Persistent Cough After Cold Medicine: When Duration, Not Dose, Matters
The article explains that ongoing cough often reflects a changed pathology rather than insufficient medication, focusing on OTC antitussives and typical cough duration.
Studien & Berichte
27. Sept. 2026•1 Min. Lesezeit
Pharmacologic Management of Acute Cough and Sputum: Guidelines for Antitussives and Expectorants
The article outlines classification of cough duration, differentiates suppression vs expectoration, and reviews medication contraindications for treating cough and sputum.
Studien & Berichte
27. Sept. 2026•1 Min. Lesezeit
Laughter Therapy Reduces Dyspnea in COPD Patients Comparable to Lip Breathing, Small Study Shows
A small 63‑patient study found that laughter therapy alleviated breathlessness in COPD patients to a degree similar to pursed‑lip breathing, with benefits lasting a month after an 8‑week program.
Studien & Berichte
27. Sept. 2026•1 Min. Lesezeit
Common Cold in Adults and Children: Frequency, Symptoms, and Pathophysiology
The article outlines how often colds occur, highlights cough and sputum as quality‑of‑life issues, and explains the underlying mechanisms involving rhinovirus, coronavirus and RSV.
Studien & Berichte
27. Sept. 2026•1 Min. Lesezeit
Study Links Better Physical Function to Improved Hearing in Older Adults
South Carolina researchers found that higher physical function scores correlate with better hearing among adults 50‑80, per a Scientific Reports study.
Studien & Berichte
27. Sept. 2026•1 Min. Lesezeit
Amivantamab + Lazertinib Shows Survival Benefit Over Osimertinib in EGFR‑Mutated NSCLC
At WCLC 2026, data showed the amivantamab‑lazertinib combo improved progression‑free and overall survival versus osimertinib, highlighting a shift to combination regimens and shared decision‑making.